A multi-centre clinical trial evaluating safety and patients' ability to independently use the medicinal product indicated in the treatment of erectile dysfunction

Adamed Pharma S.A.0 个研究点目标入组 400 人开始时间: 2019年9月26日最近更新: 2021年11月8日

试验速览

暂无简介。

•1. Sex: male.
•2. Patients aged 18 years and older.
•3. Patients able to understand and follow the study procedures.
•4. Patients who report erectile dysfunction during the clinical examination.
•5. Patients who are willing to use pharmacological treatment of erectile dysfunction.
•6. Patients who have had at least one visit to a cardiologist over the past two years and remain under his care due to the diagnosed disorders (additional criterion only for inclusion into the group of patients with cardiac disorders – at least 80 patients in the study)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 300
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 100

•1. Lack of reading and writing skills or comprehension in Polish.
•2. Severe physical or mental concomitant disease that might hamper the realization of the trial according to the protocol.
•3. Legal issues (eg. incapacitation) or others that make the patient unable to fully understand the purpose of the study, description of its course and possible consequences.
•4. Unreliability or lack of cooperation.

发起方